pancreatic-cancer

Documents about pancreatic-cancer

• Clinical and translational aspects of malignant progression and pancreatic cancer#208686GUPEA
• Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories#238606arXiv CS
• Suppression of endothelial cell FAK expression reduces pancreatic ductal adenocarcinoma metastasis after gemcitabine treatment#291412Gestión del Repositorio Documental de la Universidad de Salamanca
• Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer.#295125NCBI PubMed Central
• Clinical benefits of deep learning-assisted ultrasound in predicting lymph node metastasis in pancreatic cancer patients.#305360NCBI PubMed Central
• Silencing the Signal: The Metastasis Suppressor NDRG1 Disrupts Small Extracellular Vesicle-Mediated Crosstalk in Pancreatic Cancer.#327057NCBI PubMed Central
• Conversational Artificial Intelligence-Enabled Precision Oncology Reveals Context-Specific TGFβ and JAK/STAT Alterations in Pancreatic Cancer#359689bioRxiv / medRxiv
• CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer#383559ClinicalTrials.gov
• Dietary‐Derived Corchorus olitorius L. Extract Suppresses KRAS‐Mutant Pancreatic Cancer by Activating Ferritinophagy‐Dependent Ferroptosis.#615938NCBI PubMed Central
• Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study#676458Europe PMC
• AI-assisted design and virtual profiling of targeted degraders for pancreatic cancer therapy via PROTAC technology.#685590NCBI PubMed Central
• An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors#801143ClinicalTrials.gov
• The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease#862786ClinicalTrials.gov
• S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer#882531ClinicalTrials.gov
• The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly#121266ClinicalTrials.gov
• Interpretable miRNA-based prediction model for early detection of pancreatic cancer: Development and cross-platform validation#152670PLOS
• A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)#861906ClinicalTrials.gov
• Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum#890593ClinicalTrials.gov
• BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion#883256ClinicalTrials.gov
• [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications#855742ClinicalTrials.gov
• A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer#881553ClinicalTrials.gov
• A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation#882960ClinicalTrials.gov
• Concerted Action of Targeted Nucleic Acid Therapeutics as Flexible, Precision and Personalized Cancer Treatment#427427HAL (France)
• Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer models.#15019NCBI PubMed Central
• The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line#153461PMC Full-Text (OAI)
• Characterization of a pancreatic cancer GWAS signal suggests PDX1 buffers stress in the exocrine pancreas#180181bioRxiv / medRxiv
• From Bench to Bedside: The Path Toward Real-World Translation for Artificial Intelligence in Pancreatic Cancer Detection.#265476NCBI PubMed Central
• A clinician-centric intelligent method towards reliable pancreatic cancer vascular invasion assessment: a retrospective, multi-centre study.#266941NCBI PubMed Central
• The KN510713 Study in Combination With mFOLFIRINOX#870593ClinicalTrials.gov
• The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study#882485ClinicalTrials.gov
• Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)#885025ClinicalTrials.gov
• The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma#907838ClinicalTrials.gov
• Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial#804069ClinicalTrials.gov
• GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma#870624ClinicalTrials.gov
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies#803666ClinicalTrials.gov
• A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors#863287ClinicalTrials.gov
• Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers#853918ClinicalTrials.gov
• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors#332761ClinicalTrials.gov
• T-EUS for Gastrointestinal Disorders: A Multicenter Registry#872913ClinicalTrials.gov
• Investigation of molecular immune regulation mechanisms and therapeutic target prediction in pancreatic cancer based on bioinformatics and genetics.#122790NCBI PubMed Central
• Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer#153471PMC Full-Text (OAI)
• Rapid autofluorescence based 3D optical imaging of the pancreatic cancer milieu at mesoscopic scale - stain-free volumetric segmentation.#255239NCBI PubMed Central
• Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer.#368200NCBI PubMed Central
• Nonstop gated cone-beam computed tomography for respiratory gating pancreatic cancer radiotherapy using dual-domain deep learning reconstruction.#437083NCBI PubMed Central
• Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine.#636330NCBI PubMed Central
• Trajectories of quality of life in pancreatic cancer survivors during the first year after surgery: a longitudinal study.#645137NCBI PubMed Central
• The impact of neighborhood socioeconomic deprivation on metastatic pancreatic cancer treatment and survival: An incidence-based, causally-structured observational study#663850bioRxiv / medRxiv
• Incidence of POPF in the Resection of the Left Pancreas With RFAT#880028ClinicalTrials.gov
• A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .#909855ClinicalTrials.gov
• Synergistic Sensitization of Pancreatic Cancer Cells by Nanosecond Pulsed Electric Fields and Cold Atmospheric Plasma Via Amplifying ROS and Apoptotic Signaling#449650ODU Digital Commons